CN Patent

CN1761671A — 用作PDE7抑制剂的4－氨基噻吩并[2,3－d]嘧啶－6－甲腈衍生物

Assigned to Almirall SA · Expires 2006-04-19 · 20y expired

What this patent protects

本发明公开了具有通式(I)化学结构的新型4－氨基噻吩并[2，3－d]嘧啶－6－甲腈衍生物和其药物学上可接受的盐、它们的制备方法、包含它们的药用组合物以及它们在治疗、预防或抑制通过抑制PDE7而缓解的病症、疾病和紊乱中的用途。

USPTO Abstract

本发明公开了具有通式(I)化学结构的新型4－氨基噻吩并[2，3－d]嘧啶－6－甲腈衍生物和其药物学上可接受的盐、它们的制备方法、包含它们的药用组合物以及它们在治疗、预防或抑制通过抑制PDE7而缓解的病症、疾病和紊乱中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN1761671A
Jurisdiction
CN
Classification
—
Expires
2006-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Almirall SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.